A share price of Atyr Pharma Inc [ATYR] is currently trading at $0.97, down -8.89%. An important factor to consider is whether the stock is rising or falling in short-term value. The ATYR shares have gain 17.12% over the last week, with a monthly amount drifted -83.98%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Atyr Pharma Inc [NASDAQ: ATYR] stock has seen the most recent analyst activity on September 16, 2025, when RBC Capital Mkts downgraded its rating to a Sector Perform but kept the price target unchanged to $1.50 for it. Previously, Wells Fargo downgraded its rating to Equal Weight on September 15, 2025, and kept the price target unchanged to $1. On September 15, 2025, downgrade downgraded it’s rating to Market Perform but maintained its price target of $1 on the stock. H.C. Wainwright downgraded its rating to a Neutral. Cantor Fitzgerald downgraded its rating to a Neutral. Leerink Partners started tracking with a Outperform rating for this stock on February 18, 2025, and assigned it a price target of $16. In a note dated January 06, 2025, Cantor Fitzgerald initiated an Overweight rating.
Atyr Pharma Inc experienced fluctuations in its stock price throughout the past year between $0.68 and $7.29. Currently, Wall Street analysts expect the stock to reach $5.13 within the next 12 months. Atyr Pharma Inc [NASDAQ: ATYR] shares were valued at $0.97 at the most recent close of the market. An investor can expect a potential return of 428.87% based on the average ATYR price forecast.
Analyzing the ATYR fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.66, Equity is -0.93 and Total Capital is -0.81. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.17.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Atyr Pharma Inc [NASDAQ:ATYR] is 5.63. On the other hand, the Quick Ratio is 5.63, and the Cash Ratio is 1.11.
Transactions by insiders
Recent insider trading involved SCHIMMEL PAUL, Director, that happened on Oct 08 ’25 when 0.68 million shares were purchased. Director, SCHIMMEL PAUL completed a deal on Oct 09 ’25 to buy 0.32 million shares. Meanwhile, Director Gross Jane A bought 3750.0 shares on Mar 17 ’25.
